Pharvaris NV
Research Pharvaris NV (PHVS) on Bullrun: market cap USD 2.43B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPHVS
- ExchangeNASDAQ
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.43B
- Financial periodQ1 2026
- Net income-USD 168.56M
- Free cash flow-USD 48.82M
Valuation Snapshot
latest market cap is USD 2.43B.
About Pharvaris NV
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
Frequently asked questions
What is Pharvaris NV's market cap?
Pharvaris NV's market capitalization is USD 2.43B.
What does Pharvaris NV do?
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.